Virtual Library

Start Your Search

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

Filter Results:

Show Only Available Presentations

  • +

    WS05 - Social Media + Communications Workshop

    • Type: Workshop
    • Track: N/A
    • Presentations: 6
    • Coordinates: 8/06/2022, 09:00 - 11:00, Lehar 2
  • +

    EP02.03 - Early Stage Non-small Cell Lung Cancer - Surgery

    • Type: E-Poster
    • Track: Early Stage Non-small Cell Lung Cancer - Surgery
    • Presentations: 28
    • Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
  • +

    EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy

    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • Presentations: 108
    • Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
    • +

      EP08.01-044 - A Phase 2 Multi-Cohort Study of Tiragolumab, Atezolizumab and Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Cancer

      Author(s): Joshua Reuss

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      EP08.01-087 - First-Line Pembrolizumab-Combination Therapy for Advanced Squamous NSCLC: Real-World Outcomes at US Oncology Practices

      Author(s): Stephen V. Liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • Presentations: 171
    • Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
    • +

      EP08.02-041 - NVL-520, a Highly Selective ROS1 Inhibitor, in Patients with Advanced ROS1-Positive Solid Tumors: The Phase 1/2 ARROS-1 Study

      Author(s): Alexander Drilon

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      EP08.02-098 - Phase 2 EVOKE-02 Study of Sacituzumab Govitecan and Pembrolizumab±Platinum in First-Line Metastatic NSCLC

      Author(s): Martin Reck

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    EP14.01 - Small Cell Lung Cancer and Neuro-endocrine Tumors - Informing ES-SCLC

    • Type: E-Poster
    • Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - Informing ES-SCLC
    • Presentations: 23
    • Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
    • +

      EP14.01-015 - IMforte: A Phase III Study of Lurbinectedin and Atezolizumab Versus Atezolizumab as Maintenance Therapy in ES-SCLC

      Author(s): Luis Paz-Ares

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      EP14.01-020 - Trial in Progress: [177Lu]Lu-DOTA-TATE Combination Therapy in Treatment-Naïve Extensive Stage Small Cell Lung Cancer

      Author(s): Stephen V. Liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics

    • Type: E-Poster
    • Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
    • Presentations: 46
    • Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
    • +

      EP16.03-021 - Developing of EGFR resistant mutations to Tyrosine Kinase Inhibitors (TKI) in Non-Small Cell Lung Cancer (NSCLC)

      Author(s): Luis Raez, MD, FACP, FCCP

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA05 - Immune Landscape and Molecular Profiling of Lung Cancer

    • Type: Mini Oral
    • Track: Tumor Biology and Biomarkers
    • Presentations: 13
    • Moderators:Luis Paz-Ares
    • Coordinates: 8/07/2022, 15:45 - 16:45, Hall C8
    • +

      MA05.08 - MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer (NSCLC) by Specific Mutation, Histology, and Smoking History

      16:17 - 16:22  |  Author(s): Jennifer A. Marks

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    IBS07 - Interactive Multidisciplinary Thoracic Tumour Board (Ticketed Session) (In-person Access Only)

    • Type: Interactive Breakfast Session
    • Track: Early Stage Non-small Cell Lung Cancer?- Neoadjuvant and Adjuvant Systemic Therapy (Multi-Modality Treatment, Immunotherapy, Molecular Targeted Treatments)
    • Presentations: 1
    • Coordinates: 8/08/2022, 07:30 - 08:15, Hall C1
    • +

      IBS07.01 - Interactive Multidisciplinary Thoracic Tumour Board

      07:30 - 08:15  |  Author(s): Stephen V. Liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA07 - Is There Still a Role for Chemotherapy Alone in the Management of NSCLC?

    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
    • Presentations: 10
    • +

      OA07.04 - Overall Survival in Patients With Advanced NSCLC Receiving Taxane-Containing Regimen After Exposure to Immunotherapy and Platinum-Doublet

      11:12 - 11:22  |  Author(s): Stephen V. Liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    LA02 - Lectureship Awards - Monday (Live Streamed Session)

    • Type: Awards
    • Track: N/A
    • Presentations: 4
    • +

      LA02.05 - Heine H. Hansen Lectureship Award for Small Cell Lung Cancer

      14:02 - 14:17  |  Author(s): Stephen V. Liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.